Cannabis Europa London 2024 brings together policymakers, business leaders, healthcare professionals, and innovators at the forefront of Europe’s rapidly evolving cannabis landscape. With landmark regulatory shifts in Germany and Greece, a maturing medical market in the UK, and pivotal experiments underway in the Netherlands and Czech Republic, Europe is entering a defining era for cannabis reform.
Across two days of discussion and debate, delegates will gain insights into the challenges and opportunities shaping both medical and adult-use markets. From Germany’s potential role as Europe’s launchpad for legalisation, to the UK’s fast-growing patient base, to the role of cannabis in sports recovery and pharmaceutical integration, this year’s agenda tackles the most pressing issues for the industry’s future. Cannabis Europa London 2024 is not just a conference—it’s where Europe’s cannabis industry connects, collaborates, and sets the direction for years to come.
Our speakers are global thought-leaders driving change in policy, research, and commerce. Hear their insights, challenge your thinking, and leave with actionable strategies.
Subscribe to receive the latest updates on cannabis regulation, investment, and innovation in Europe.
Join the leading voices in cannabis policy and business. We’re proud to partner with organisations at the forefront of cannabis innovation, investment, and regulation.
We’re proud to partner with organisations at the forefront of cannabis innovation, investment, and regulation.
Cannabis Europa brings together the brightest minds in cannabis policy, business, and investment. Over two days in London, you’ll engage with policymakers, investors, scientists, and entrepreneurs to explore opportunities in one of the world’s fastest-evolving markets.
The debate around cannabis reform in the United Kingdom has grown more structured, more evidence-based, and more commercially significant in recent years. Yet legislative change at the national level remains absent. Understanding why — and what the realistic trajectory looks like — matters as much to investors and business leaders as it does to policymakers […]
The European cannabis landscape is entering a high-growth phase, marked by the arrival of seasoned entrepreneurs and major institutional shifts. As Cannabis Europa London 2026 approaches, the first wave of speakers has been announced, highlighting a diverse intersection of pharmaceutical innovation, global policy, and venture capital. Martin Dickie MBE & Waterside Pharmaceuticals A major highlight […]
With dedicated sessions on M&A, investment, pricing strategy and market access, Cannabis Europa London 2026 is the room where Europe’s cannabis industry does business. There are cannabis conferences, and then there are the events where decisions actually get made. Cannabis Europa London has established itself as the latter—a curated gathering of the operators, investors, policymakers […]
Germany and Poland are tightening the rules on online prescribing. The ripple effects will reshape medical cannabis access across the continent. Telemedicine didn’t just support the growth of European medical cannabis—it turbocharged it. Online consultations and e-prescriptions lowered barriers for patients, expanded clinic reach beyond urban centres, and drove a surge in imports across the […]
